CIM
Contravisory Investment Management Portfolio holdings
AUM
$508M
1-Year Return
23.42%
This Quarter Return
+5.78%
1 Year Return
+23.42%
3 Year Return
+97.74%
5 Year Return
+193.46%
10 Year Return
+427.78%
AUM
$259M
AUM Growth
+$626K
(+0.24%)
Cap. Flow
-$9.87M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
27.16%
Holding
343
New
40
Increased
92
Reduced
61
Closed
71
Top Buys
| 1 |
Microsoft
MSFT
|
$6.03M |
| 2 |
Republic Services
RSG
|
$5.83M |
| 3 |
Kimberly-Clark
KMB
|
$5.8M |
| 4 |
Procter & Gamble
PG
|
$4.18M |
| 5 |
Darden Restaurants
DRI
|
$4.04M |
Top Sells
| 1 |
Elevance Health
ELV
|
$4.87M |
| 2 |
HP
HPQ
|
$4.75M |
| 3 |
Humana
HUM
|
$4.26M |
| 4 |
Markel Group
MKL
|
$4.11M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$4.1M |
Sector Composition
| 1 | Technology | 26.71% |
| 2 | Consumer Staples | 11.11% |
| 3 | Industrials | 10.37% |
| 4 | Financials | 9.14% |
| 5 | Healthcare | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Brookfield
BN
$99.5B
| $67K | 0.03% |
2,636
| – | – |
|
202
CME Group
CME
$94.4B
| $67K | 0.03% |
344
+64
| +23% | +$12.5K |
|
203
CSX Corp
CSX
$60.6B
| $67K | 0.03% |
2,604
+450
| +21% | +$11.6K |
|
204
Chubb
CB
$111B
| $66K | 0.03% |
+447
| New | +$66K |
|
205
Charter Communications
CHTR
$35.7B
| $66K | 0.03% |
+167
| New | +$66K |
|
206
Ecolab
ECL
$77.6B
| $66K | 0.03% |
336
+48
| +17% | +$9.43K |
|
207
Canadian Pacific Kansas City
CP
$70.3B
| $65K | 0.03% |
1,375
-15
| -1% | -$709 |
|
208
Diageo
DEO
$61.3B
| $65K | 0.03% |
377
-3
| -0.8% | -$517 |
|
209
Lowe's Companies
LOW
$151B
| $65K | 0.03% |
641
+87
| +16% | +$8.82K |
|
|
INFO
210
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $65K | 0.03% |
1,013
| – | – |
|
211
Lithia Motors
LAD
$8.74B
| $64K | 0.02% |
540
| – | – |
|
212
Sherwin-Williams
SHW
$92.9B
| $64K | 0.02% |
417
+81
| +24% | +$12.4K |
|
213
American Tower
AMT
$92.9B
| $62K | 0.02% |
+302
| New | +$62K |
|
|
CELG
214
DELISTED
Celgene Corp
CELG
| $62K | 0.02% |
+670
| New | +$62K |
|
215
Eli Lilly
LLY
$652B
| $61K | 0.02% |
+548
| New | +$61K |
|
216
SPDR Gold Trust
GLD
$112B
| $60K | 0.02% |
450
| – | – |
|
217
Verizon
VZ
$187B
| $60K | 0.02% |
1,053
+485
| +85% | +$27.6K |
|
218
Infosys
INFY
$67.9B
| $59K | 0.02% |
5,522
| – | – |
|
219
Canadian National Railway
CNI
$60.3B
| $57K | 0.02% |
613
| – | – |
|
220
Intel
INTC
$107B
| $55K | 0.02% |
1,146
+803
| +234% | +$38.5K |
|
221
Ericsson
ERIC
$26.7B
| $54K | 0.02% |
5,689
| – | – |
|
222
AstraZeneca
AZN
$253B
| $53K | 0.02% |
1,273
| – | – |
|
223
Elbit Systems
ESLT
$22.3B
| $53K | 0.02% |
+352
| New | +$53K |
|
224
GSK
GSK
$81.5B
| $51K | 0.02% |
1,029
| – | – |
|
225
Novartis
NVS
$251B
| $50K | 0.02% |
+552
| New | +$50K |
|